Genzyme plays down latest Cerezyme impurity
This article was originally published in Scrip
Executive Summary
Genzyme has just revealed that it found an impurity in a single vial of its Gaucher's disease drug Cerezyme (imiglucerase) from its fill-finish facility in Waterford, Ireland last December.